GLPwatch
Trials (2167)
Page 17 of 37.
- The Transit Bipartition With the Use of a Metallic Anastomosis Clip and Circular Fundocorporeal Gastroplication
- A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight
- A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
- Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
- Emulation of the SOUL Diabetes Trial in Healthcare Claims
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
- A Study to Evaluate the Safety of Exposure to Wegovy During Pregnancy
- PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatide
- Exenatide and Weight Loss for Diabetes Prevention
- Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
- Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
- A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
- MIST (Metabolic Intervention With Semaglutide and THR-β Therapy) Trial
- Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
- Evaluation of Exenatide in Patients With Diabetic Neuropathy
- Improved Treatment and Monitoring of Alzheimer's Disease
- A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
- Comparison of Body Composition Changes With Weight Loss Interventions
- Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
- Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
- A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
- BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
- Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
- Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
- A Study of Tirzepatide in Overweight and Very Overweight Participants
- A Study of LY3437943 in Healthy Participants and Participants With Impaired Renal Function
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
- A Study of Enlicitide Decanoate (MK-0616) and Semaglutide in Healthy Adult Participants (MK-0616-023)
- Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)
- Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese Adults
- Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health
- A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus
- The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- Tailoring Obesity Treatment Trial
- A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)
- A Study of LY3025876 in Participants With Diabetes
- UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study
- A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Dietary Peanuts and Nutrition-Related Outcomes
- Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
- The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and Obesity
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function
- GLP-1 Analogue Treatment in Uncontrolled Type 1 Diabetic Patients
- Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
- SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease
- GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery
- The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes